Selegiline Hydrochloride
NDC 72319-006, Selegiline Hydrochloride, tablet, from i3 Pharmaceuticals, LLC.
- Product NDC
- 72319-006
- Status
- Listed
- Labeler
- i3 Pharmaceuticals, LLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA074672
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/72319-006 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- SELEGILINE HYDROCHLORIDE5 mg/1
Pharmacologic classes
Monoamine Oxidase Inhibitor [EPC]; Monoamine Oxidase Inhibitors [MoA]; Monoamine Oxidase Type B Inhibitor [EPC]; Monoamine Oxidase-B Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 72319-006-02 | 72319000602 | 60 TABLET in 1 BOTTLE (72319-006-02) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/c81e983b-455d-2e65-e053-2a95a90a3123NADAC price for package 72319000602
GET /v1/drugs/nadac/72319000602
Use it
Look up 72319-006 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/72319-006 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 72319-006. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.